Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Wickramanayake

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|January 1, 1988
[Tumor therapy]P D Wickramanayake, V Diehl
Leber, Magen, Darm|January 1, 1984
[Late development of colonic neoplasms after uretero-sigmoidostomy]P D Wickramanayake, H O Klein
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1991
[Myelodysplastic syndrome (preleukemia)]P D Wickramanayake, J Pallenschat, V Diehl
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1991
[Chronic myelomonocytic leukemia--myelodysplastic syndrome]P D Wickramanayake, J Pallenschat, V Diehl
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1996
[Adjuvant systemic therapy of breast carcinoma]P D Wickramanayake, I Katay, A Josting, et al.
Investigational New Drugs|January 1, 1984
Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide)H O Klein, P D Wickramanayake, E Christian, et al.
American Journal of Hematology|August 1, 1996
Quantitative analysis of MDR-1 gene expression in acute myeloid leukemia by reverse transcription polymerase chain reactionQ X Cao, A Schulz, C Scheid, et al.
Klinische Wochenschrift|October 3, 1983
[Modification of an Ehrlich ascites tumor growth by various standardized feedings]H O Klein, E Christian, C Coerper, et al.
Cancer|September 15, 1984
Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)H O Klein, P D Wickramanayake, E Christian, et al.
Cancer Treatment Reviews|September 1, 1983
Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesnaH O Klein, P D Wickramanayake, E Christian, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Medizinische Monatsschrift Fur Pharmazeuten|January 1, 1988
[Tumor therapy]P D Wickramanayake, V Diehl
Leber, Magen, Darm|January 1, 1984
[Late development of colonic neoplasms after uretero-sigmoidostomy]P D Wickramanayake, H O Klein
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1991
[Myelodysplastic syndrome (preleukemia)]P D Wickramanayake, J Pallenschat, V Diehl
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1991
[Chronic myelomonocytic leukemia--myelodysplastic syndrome]P D Wickramanayake, J Pallenschat, V Diehl
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1996
[Adjuvant systemic therapy of breast carcinoma]P D Wickramanayake, I Katay, A Josting, et al.
Investigational New Drugs|January 1, 1984
Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide)H O Klein, P D Wickramanayake, E Christian, et al.
American Journal of Hematology|August 1, 1996
Quantitative analysis of MDR-1 gene expression in acute myeloid leukemia by reverse transcription polymerase chain reactionQ X Cao, A Schulz, C Scheid, et al.
Klinische Wochenschrift|October 3, 1983
[Modification of an Ehrlich ascites tumor growth by various standardized feedings]H O Klein, E Christian, C Coerper, et al.
Cancer|September 15, 1984
Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)H O Klein, P D Wickramanayake, E Christian, et al.
Cancer Treatment Reviews|September 1, 1983
Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesnaH O Klein, P D Wickramanayake, E Christian, et al.
Pageof 3